Table 3.
Univariate and multivariate analyses of disease-free survival in patients with gastric cancer
| Prognostic variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Age (years) | 1.005 (0.700–1.444) | 0.977 | – | – |
| Sex | 0.782 (0.536–1.139) | 0.200 | – | – |
| Histological grade | 0.866 (0.601–1.249) | 0.442 | – | – |
| TNM stage | 2.187 (1.537–3.111) | 0.000 | 0.996 (0.583–1.703) | 0.989 |
| T stage | 2.338 (1.507–3.627) | 0.000 | 1.589 (0.939–2.687) | 0.084 |
| N stage | 2.086 (1.407–3.093) | 0.000 | 1.587 (0.955–2.639) | 0.075 |
| M stage | 3.820 (2.163–6.747) | 0.000 | 2.857 (1.572–5.129) | 0.001 |
| Tumor location | 0.651 (0.461–0.920) | 0.015 | 0.850 (0.590–1.223) | 0.381 |
| Tumor size | 1.882 (1.317–2.690) | 0.001 | 1.302 (0.885–1.915) | 0.181 |
| NETO2 expression | 1.652 (1.154–2.364) | 0.006 | 1.463 (1.016–2.107) | 0.041 |